Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hotel Grand Majestic Plaza

Jun 15, 2017 8:15 AM - Jun 16, 2017 5:00 PM

Truhlarska 16, 110 00 Prague 1, Czech Republic

DIA Workshop on Benefit-Risk Strategy


Are you aware of the key developments on the benefit-risk guidelines?

Benefit-risk guidelines continue to evolve with the EMA publishing guidance revisions as recently as this March. This workshop provides you the tools to address these changes by giving you:

  1. Overview of benefit-risk assessments
  2. Examples of challenges and solutions across different departments
  3. Impacts and interpretations of the new guidelines

EMA experts join this workshop to give you tangible insights and tips to navigate the evolving benefit-risk guidelines. The hands-on workshop structure provides you with real-world examples from regulatory and industry perspectives, and explores tangible ways to improve your best practices.

Download Registration Form


Want to learn more about DIA Workshop on Benefit-Risk Strategy? You've come to the right site!


Who should attend?

Professionals involved in benefit-risk strategy from various departments, e.g. pharmacovigilance, regulatory, clinical, drug safety, medical affairs, or medical writing.

Program leads who oversee the clinical development, dossier preparation, and post-marketing phases of the medicines life cycle.


Learning objectives

What will you gain?

New benefit-risk regulations call for a more structured and formalised process. This workshop will:

  • Increase your understanding of the current benefit and risk landscape
  • Empower you to perform benefit-risk management more effectively within your organisation
  • Create a toolkit for you to address tactical components of risk assessments, including data collection and digital innovation

Program Committee

  • Martin  Huber, MPH, MPharm
    Martin Huber, MPH, MPharm Pharmacovigilance Risk Assessment Committee (PRAC) Vice Chair
    Federal Institute for Drugs and Medical Devices (BfArM), Germany
  • Steve  Mayall, PhD
    Steve Mayall, PhD Director
    Huron Consulting Group, United Kingdom
  • Jan  Petracek, MD, MSc
    Jan Petracek, MD, MSc CEO
    Ivigee, Czech Republic
  • Steffen  Thirstrup, MD, PhD
    Steffen Thirstrup, MD, PhD Chief Medical Officer
    European Medicines Agency, Netherlands

Digital Learning Catalog

DIA Learning: eLearning Soultions

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.